According to the Zhitong Finance App, Huayuan Biotech (300401.SZ) issued an announcement. The company recently received the “Certificate of Export of APIs from the Zhejiang Drug Administration of the People's Republic of China” and the “People's Republic of China Drug Export Sales Certificate” from the Zhejiang Drug Administration, which are valid until September 1, 2029. Obtaining the above certification shows that the company's production quality management system complies with EU and ICHQ7 pharmaceutical GMP requirements, which helps the company expand its API business in the global market and enhance the company's competitiveness in the international market.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.